Literature DB >> 2555749

Increased alpha 2- and beta 2-adrenergic receptors in cerebral microvessels in Alzheimer disease.

R N Kalaria1, S I Harik.   

Abstract

Adrenergic receptors exist in brain microvessels which are innervated by noradrenergic locus ceruleus neurons. Biochemical and pathological studies indicate locus ceruleus degeneration in Alzheimer disease (AD), which can cause adrenergic receptor alterations in brain microvessels. To assess this, we studied adrenergic receptors in human brain microvessels from AD subjects and age-matched controls by ligand binding methods. Total beta receptors of cerebral microvessels and beta 2 receptors, the type which predominates in microvessels, were significantly increased in AD. Compared to the cerebral cortex, there was a paucity of alpha 1-adrenergic receptors in cerebral microvessels, and they did not change in AD. Binding to alpha 2 receptors in cerebral microvessels was approximately 50% of that in the cortex, and these receptors increased by approximately 60% in cerebral microvessels of AD subjects. These findings suggest adrenergic receptor 'upregulation' in response to noradrenergic deafferentation in AD, which may have functional consequences at the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555749     DOI: 10.1016/0304-3940(89)90231-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients.

Authors:  A Russo-Neustadt; C W Cotman
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 3.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

4.  The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain.

Authors:  Ramakrishna Devaki; Sharada Shankar Rao; Subhash M Nadgir
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

5.  Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

Authors:  Elena V Wisely; Yang K Xiang; Salvatore Oddo
Journal:  Hum Mol Genet       Date:  2014-03-13       Impact factor: 6.150

Review 6.  Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications.

Authors:  Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc
Journal:  Antioxid Redox Signal       Date:  2021-09-17       Impact factor: 7.468

Review 7.  Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).

Authors:  Mubashir Hassan; Qamar Abbas; Sung-Yum Seo; Saba Shahzadi; Hany Al Ashwal; Nazar Zaki; Zeeshan Iqbal; Ahmed A Moustafa
Journal:  Mol Med Rep       Date:  2018-05-22       Impact factor: 2.952

Review 8.  Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.

Authors:  Cody Slater; Qi Wang
Journal:  Clin Transl Med       Date:  2021-04

9.  Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Immun Ageing       Date:  2013-03-15       Impact factor: 6.400

10.  Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier.

Authors:  Akihiko Urayama; Shinya Dohgu; Sandra M Robinson; William S Sly; Jeffery H Grubb; William A Banks
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.